Ratio Therapeutics

2 followers


A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Employees

11-50

Links


Org chart

Jack Hoppin
Chairman & CEO
Collapse
John Babich
Director, President, & Chief Scientific Officer
Jacob Hesterman
Chief Data Officer
John M. Garvey
Chief Legal Officer & General Counsel
Matthias Friebe
Chief Technology Officer
Allan Green
Director & Regulatory Consultant
Bill Cupelo
Chief Business Officer
Marc Becker
CFO & COO